Overview |
bsm-51545M |
LRRK2 Monoclonal Antibody |
WB, IHC-P |
Human, Mouse |
Specifications |
Unconjugated |
Mouse |
Recombinant human PARK8 (LRRK2) (Fragment) (His-tagged). |
Monoclonal |
L2F6 |
IgG1 |
0.5ug/ul |
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target |
120892 |
Q5S007 |
Cytoplasm, Cell membrane |
Dardarin; Leucine rich repeat kinase 2; LRRK 2; LRRK-2; PARK 8; PARK8; ROCO 2; ROCO-2; ROCO2; Leucine-rich repeat serine/threonine-protein kinase 2; Dardarin; LRRK2_HUMAN; augmented in rheumatoid arthritis 17; AURA17; Leucine rich repeat kinase 2; RIPK7. |
May play a role in the phosphorylation of proteins central to Parkinson disease. Phosphorylates PRDX3. May also have GTPase activity. |
Application Dilution |
WB |
=1:500-1000,IHC-P=1:50-100, |
IHC-P |
1:200-400 |